NASDAQ:SWAV

ShockWave Medical Stock Forecast, Price & News

$131.01

-1.37 (-1.03 %)

(As of 01/21/2021 11:51 AM ET)

Add

Compare

Today's Range

$128.16

Now: $131.01▼

$133.33

50-Day Range

$86.25

MA: $106.72▼

$142.05

52-Week Range

$22.01

Now: $131.01▼

$143.79

Volume5,577 shs

Average Volume513,833 shs

Market Capitalization$4.49 billion

P/E RatioN/A

Dividend YieldN/A

Beta1.26

ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.

Overall MarketRank^™

1.17 out of 5 stars

Medical Sector

849th out of 1,928 stocks

Surgical & Medical Instruments Industry

84th out of 170 stocks

1.2 Analyst's Opinion

Consensus Rating
ShockWave Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $97.33, ShockWave Medical has a forecasted downside of 26.5% from its current price of $132.38.
Amount of Analyst Coverage
ShockWave Medical has only been the subject of 4 research reports in the past 90 days.

2.4 Community Rank

Outperform Votes
ShockWave Medical has received 94 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ShockWave Medical has received 102 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ShockWave Medical has received 52.04% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ShockWave Medical and other stocks. Vote “Outperform” if you believe SWAV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ShockWave Medical does not currently pay a dividend.
Dividend Growth
ShockWave Medical does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ShockWave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $39,962,022.00 in company stock.
Percentage Held by Insiders
Only 15.30% of the stock of ShockWave Medical is held by insiders.
Percentage Held by Institutions
88.84% of the stock of ShockWave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for ShockWave Medical are expected to grow in the coming year, from ($1.94) to ($1.10) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ShockWave Medical is -65.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ShockWave Medical is -65.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ShockWave Medical has a P/B Ratio of 19.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:SWAV

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.shockwavemedical.com

Phone510-279-4262

Employees284

Debt

Debt-to-Equity Ratio0.06

Current Ratio12.21

Quick Ratio10.84

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$42.93 million

Price / Sales104.55

Cash FlowN/A

Price / Cash FlowN/A

Book Value$6.81 per share

Price / Book19.24

Profitability

EPS (Most Recent Fiscal Year)($2.14)

Net Income$-51,110,000.00

Net Margins-108.73%

Return on Equity-30.28%

Return on Assets-25.31%

Miscellaneous

Outstanding Shares34,260,000

Market Cap$4.49 billion

Next Earnings Date2/17/2021 (Confirmed)

OptionableNot Optionable

$131.01

-1.37 (-1.03 %)

(As of 01/21/2021 11:51 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive SWAV News and Ratings via Email

Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.

ShockWave Medical (NASDAQ:SWAV) Frequently Asked Questions

How has ShockWave Medical's stock been impacted by COVID-19 (Coronavirus)?

ShockWave Medical's stock was trading at $34.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SWAV stock has increased by 280.4% and is now trading at $131.01.
View which stocks have been most impacted by COVID-19.

Is ShockWave Medical a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ShockWave Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SWAV, but not buy additional shares or sell existing shares.
View analyst ratings for ShockWave Medical or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than ShockWave Medical?

Wall Street analysts have given ShockWave Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ShockWave Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as ShockWave Medical's CEO?

1,428 employees have rated ShockWave Medical CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 59% among ShockWave Medical's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is ShockWave Medical's next earnings date?

ShockWave Medical is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for ShockWave Medical.

How can I listen to ShockWave Medical's earnings call?

ShockWave Medical will be holding an earnings conference call on Wednesday, February 17th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were ShockWave Medical's earnings last quarter?

ShockWave Medical, Inc. (NASDAQ:SWAV) released its earnings results on Monday, November, 9th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.55) by $0.17. The company earned $19.60 million during the quarter, compared to the consensus estimate of $14.69 million. ShockWave Medical had a negative return on equity of 30.28% and a negative net margin of 108.73%. The firm's quarterly revenue was up 73.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.46) earnings per share.
View ShockWave Medical's earnings history.

What price target have analysts set for SWAV?

6 brokerages have issued twelve-month price objectives for ShockWave Medical's stock. Their forecasts range from $23.00 to $134.00. On average, they anticipate ShockWave Medical's share price to reach $97.33 in the next twelve months. This suggests that the stock has a possible downside of 25.7%.
View analysts' price targets for ShockWave Medical or view Wall Street analyst' top-rated stocks.

Who are some of ShockWave Medical's key competitors?

Some companies that are related to ShockWave Medical include NovoCure (NVCR), Abiomed (ABMD), Penumbra (PEN), iRhythm Technologies (IRTC), Hill-Rom (HRC), Globus Medical (GMED), Haemonetics (HAE), Nevro (NVRO), Inspire Medical Systems (INSP), Integra LifeSciences (IART), Tandem Diabetes Care (TNDM), Inari Medical (NARI), ICU Medical (ICUI), Glaukos (GKOS) and Cantel Medical (CMD).
View all of SWAV's competitors.

What other stocks do shareholders of ShockWave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), The Walt Disney (DIS), Square (SQ), The Trade Desk (TTD), salesforce.com (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

Who are ShockWave Medical's key executives?

ShockWave Medical's management team includes the following people:

Mr. Douglas E. Godshall, Pres, CEO & Director (Age 56, Pay $1.03M)
Mr. Daniel Puckett, CFO & Sec. (Age 57, Pay $592.29k)
Mr. Isaac Zacharias, Chief Commercial Officer (Age 46, Pay $508.65k)
Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 54)
Mr. John M. Adams, Co-Founder and Technical Advisor (Age 74)
Mr. Mike Maszy, VP of Operations
Ms. Debbie Kaster, Head of Investor Relations
Mr. Hajime Tada J.D., Gen. Counsel & Sec.
Mr. Rob Williamson Jr., VP of Sales
Mr. Robert Fletcher, VP of Marketing

When did ShockWave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is ShockWave Medical's stock symbol?

ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."

How do I buy shares of ShockWave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ShockWave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $131.01.

How big of a company is ShockWave Medical?

ShockWave Medical has a market capitalization of $4.49 billion and generates $42.93 million in revenue each year. The company earns $-51,110,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. ShockWave Medical employs 284 workers across the globe.

What is ShockWave Medical's official website?

The official website for ShockWave Medical is www.shockwavemedical.com.

How can I contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here